Atherosclerosis and Lipoproteins |
From the Lipoprotein and Atherosclerosis Research Group & Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada
Correspondence to Ruth McPherson, University of Ottawa Heart Institute, Rm H453, 40 Ruskin Street, Ottawa, Canada, K1Y 4W7. E-mail rmcpherson{at}ottawaheart.ca
Objective To determine whether expression of the human CETP transgene protects against diet-induced atherosclerosis in SR-BI deficient mice.
Methods and Results SR-BI deficient (/) mice were crossed with CETP transgenic (CETPtg) mice to produce a colony of SR-BI/ x CETPtg mice in a C57Bl/6 background. Age and sex matched groups of genetically modified and wild-type C57Bl/6 mice were fed a high fat, high cholesterol diet for 22 weeks. In both wild-type and SR-BI/ mice, expression of the CETP transgene reduced the cholesterol content and increased the density of lipoprotein particles in the HDL density range. In SR-BI/ x CETPtg mice, CETP activity inversely correlated with total plasma cholesterol levels and shifted the buoyant HDL typical of SR-BI deficiency toward a more normal density HDL particle. Atherosclerosis at the level of the aortic arch was evident in both male and female SR-BI deficient mice but occurred to a greater extent in the females. Expression of CETP markedly attenuated the development of atherosclerosis in SR-BI deficient mice fed an atherogenic diet (P<0.003).
Conclusions Expression of the human CETP transgene protects SR-BI deficient mice from atherosclerosis, consistent with a role for CETP in remodeling HDL and providing an alternative pathway for the selective uptake of HDL-CE by the liver.
To determine whether expression of the human CETP transgene protects against diet-induced atherosclerosis in SR-BI deficient (/) mice, we crossed these with CETP transgenic mice to create SR-BI/ x CETPtg mice in a C57Bl/6 background. CETP expression reduced HDL cholesterol, increased HDL density, and markedly attenuated the development of atherosclerosis.
Key Words: CETP SR-BI atherosclerosis HDL
This article has been cited by other articles:
![]() |
D. Masson, M. Koseki, M. Ishibashi, C. J. Larson, S. G. Miller, B. D. King, and A. R. Tall Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor Arterioscler Thromb Vasc Biol, December 1, 2009; 29(12): 2054 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hoekstra, D. Ye, R. B. Hildebrand, Y. Zhao, B. Lammers, M. Stitzinger, J. Kuiper, T. J. C. Van Berkel, and M. Van Eck Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production J. Lipid Res., June 1, 2009; 50(6): 1039 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tanigawa, J. T. Billheimer, J.-i. Tohyama, Y. Zhang, G. Rothblat, and D. J. Rader Expression of Cholesteryl Ester Transfer Protein in Mice Promotes Macrophage Reverse Cholesterol Transport Circulation, September 11, 2007; 116(11): 1267 - 1273. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |